Early Endosome Antigen 1 (EEA1) Peptide
-
- Target See all EEA1 products
- EEA1 (Early Endosome Antigen 1 (EEA1))
- Origin
- Human, Monkey, Mouse, Pig, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-EEA1 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- EEA1 (Early Endosome Antigen 1 (EEA1))
- Synonyms
- MST105 Peptide, MSTP105 Peptide, ZFYVE2 Peptide, im:7151048 Peptide, si:ch211-276p10.2 Peptide, A430109M19Rik Peptide, B230358H09Rik Peptide, early endosome antigen 1 Peptide, early endosome antigen 1 S homeolog Peptide, EEA1 Peptide, eea1 Peptide, Eea1 Peptide, eea1.S Peptide
- Background
- ZFYVE2, Early endosome antigen 1, Endosome-associated protein p162, Zinc finger FYVE domain-containing protein 2
- Gene ID
- 8411, 216238
- UniProt
- Q15075, Q8BL66
-